254 related articles for article (PubMed ID: 24103369)
1. Quantitative analysis of site-specific N-glycans on sera haptoglobin β chain in liver diseases.
Zhang S; Jiang K; Sun C; Lu H; Liu Y
Acta Biochim Biophys Sin (Shanghai); 2013 Dec; 45(12):1021-9. PubMed ID: 24103369
[TBL] [Abstract][Full Text] [Related]
2. N-linked glycan changes of serum haptoglobin β chain in liver disease patients.
Zhang S; Shu H; Luo K; Kang X; Zhang Y; Lu H; Liu Y
Mol Biosyst; 2011 May; 7(5):1621-8. PubMed ID: 21380457
[TBL] [Abstract][Full Text] [Related]
3. Protein expression and fucosylated glycans of the serum haptoglobin-{beta} subunit in hepatitis B virus-based liver diseases.
Shu H; Zhang S; Kang X; Li S; Qin X; Sun C; Lu H; Liu Y
Acta Biochim Biophys Sin (Shanghai); 2011 Jul; 43(7):528-34. PubMed ID: 21606158
[TBL] [Abstract][Full Text] [Related]
4. Quantitative liquid chromatography-mass spectrometry-multiple reaction monitoring (LC-MS-MRM) analysis of site-specific glycoforms of haptoglobin in liver disease.
Sanda M; Pompach P; Brnakova Z; Wu J; Makambi K; Goldman R
Mol Cell Proteomics; 2013 May; 12(5):1294-305. PubMed ID: 23389048
[TBL] [Abstract][Full Text] [Related]
5. ESI-LC-MS Method for Haptoglobin Fucosylation Analysis in Hepatocellular Carcinoma and Liver Cirrhosis.
Zhang Y; Zhu J; Yin H; Marrero J; Zhang XX; Lubman DM
J Proteome Res; 2015 Dec; 14(12):5388-95. PubMed ID: 26503433
[TBL] [Abstract][Full Text] [Related]
6. LC-MS/MS isomeric profiling of permethylated N-glycans derived from serum haptoglobin of hepatocellular carcinoma (HCC) and cirrhotic patients.
Huang Y; Zhou S; Zhu J; Lubman DM; Mechref Y
Electrophoresis; 2017 Sep; 38(17):2160-2167. PubMed ID: 28543513
[TBL] [Abstract][Full Text] [Related]
7. Abundance-ratio-based semiquantitative analysis of site-specific N-linked glycopeptides present in the plasma of hepatocellular carcinoma patients.
Lee HJ; Cha HJ; Lim JS; Lee SH; Song SY; Kim H; Hancock WS; Yoo JS; Paik YK
J Proteome Res; 2014 May; 13(5):2328-38. PubMed ID: 24628331
[TBL] [Abstract][Full Text] [Related]
8. Differential Quantitative Determination of Site-Specific Intact N-Glycopeptides in Serum Haptoglobin between Hepatocellular Carcinoma and Cirrhosis Using LC-EThcD-MS/MS.
Zhu J; Chen Z; Zhang J; An M; Wu J; Yu Q; Skilton SJ; Bern M; Ilker Sen K; Li L; Lubman DM
J Proteome Res; 2019 Jan; 18(1):359-371. PubMed ID: 30370771
[TBL] [Abstract][Full Text] [Related]
9. Analysis of serum Haptoglobin using glycoproteomics and lectin immunoassay in liver diseases in Hepatitis B virus infection.
Dalal K; Dalal B; Bhatia S; Shukla A; Shankarkumar A
Clin Chim Acta; 2019 Aug; 495():309-317. PubMed ID: 31014754
[TBL] [Abstract][Full Text] [Related]
10. Site-specific analysis of N-glycans on haptoglobin in sera of patients with pancreatic cancer: a novel approach for the development of tumor markers.
Nakano M; Nakagawa T; Ito T; Kitada T; Hijioka T; Kasahara A; Tajiri M; Wada Y; Taniguchi N; Miyoshi E
Int J Cancer; 2008 May; 122(10):2301-9. PubMed ID: 18214858
[TBL] [Abstract][Full Text] [Related]
11. Site-specific glycoforms of haptoglobin in liver cirrhosis and hepatocellular carcinoma.
Pompach P; Brnakova Z; Sanda M; Wu J; Edwards N; Goldman R
Mol Cell Proteomics; 2013 May; 12(5):1281-93. PubMed ID: 23389049
[TBL] [Abstract][Full Text] [Related]
12. A pilot study of salivary N-glycome in HBV-induced chronic hepatitis, cirrhosis, and hepatocellular carcinoma.
Qin Y; Zhong Y; Ma T; Zhang J; Yang G; Guan F; Li Z; Li B
Glycoconj J; 2017 Aug; 34(4):523-535. PubMed ID: 28389847
[TBL] [Abstract][Full Text] [Related]
13. Altered glycosylation, expression of serum haptoglobin and alpha-1-antitrypsin in chronic hepatitis C, hepatitis C induced liver cirrhosis and hepatocellular carcinoma patients.
Mondal G; Saroha A; Bose PP; Chatterjee BP
Glycoconj J; 2016 Apr; 33(2):209-18. PubMed ID: 27034286
[TBL] [Abstract][Full Text] [Related]
14. Study of serum haptoglobin and its glycoforms in the diagnosis of hepatocellular carcinoma: a glycoproteomic approach.
Ang IL; Poon TC; Lai PB; Chan AT; Ngai SM; Hui AY; Johnson PJ; Sung JJ
J Proteome Res; 2006 Oct; 5(10):2691-700. PubMed ID: 17022640
[TBL] [Abstract][Full Text] [Related]
15. Ultrasensitive characterization of site-specific glycosylation of affinity-purified haptoglobin from lung cancer patient plasma using 10 μm i.d. porous layer open tubular liquid chromatography-linear ion trap collision-induced dissociation/electron transfer dissociation mass spectrometry.
Wang D; Hincapie M; Rejtar T; Karger BL
Anal Chem; 2011 Mar; 83(6):2029-37. PubMed ID: 21338062
[TBL] [Abstract][Full Text] [Related]
16. Mass Spectrometric N-Glycan Analysis of Haptoglobin from Patient Serum Samples Using a 96-Well Plate Format.
Zhu J; Wu J; Yin H; Marrero J; Lubman DM
J Proteome Res; 2015 Nov; 14(11):4932-9. PubMed ID: 26448449
[TBL] [Abstract][Full Text] [Related]
17. Glycosylation status of haptoglobin in sera of patients with prostate cancer vs. benign prostate disease or normal subjects.
Fujimura T; Shinohara Y; Tissot B; Pang PC; Kurogochi M; Saito S; Arai Y; Sadilek M; Murayama K; Dell A; Nishimura S; Hakomori SI
Int J Cancer; 2008 Jan; 122(1):39-49. PubMed ID: 17803183
[TBL] [Abstract][Full Text] [Related]
18. N-glycomic changes in hepatocellular carcinoma patients with liver cirrhosis induced by hepatitis B virus.
Liu XE; Desmyter L; Gao CF; Laroy W; Dewaele S; Vanhooren V; Wang L; Zhuang H; Callewaert N; Libert C; Contreras R; Chen C
Hepatology; 2007 Nov; 46(5):1426-35. PubMed ID: 17683101
[TBL] [Abstract][Full Text] [Related]
19. Selective isolation and analysis of glycoprotein fractions and their glycomes from hepatocellular carcinoma sera.
Yang G; Cui T; Wang Y; Sun S; Ma T; Wang T; Chen Q; Li Z
Proteomics; 2013 May; 13(9):1481-98. PubMed ID: 23436760
[TBL] [Abstract][Full Text] [Related]
20. Analysis of serum haptoglobin fucosylation in hepatocellular carcinoma and liver cirrhosis of different etiologies.
Zhu J; Lin Z; Wu J; Yin H; Dai J; Feng Z; Marrero J; Lubman DM
J Proteome Res; 2014 Jun; 13(6):2986-97. PubMed ID: 24807840
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]